40TiP SOLTI-1802 ONAWA trial: A window of opportunity trial of onapristone (ONA) in postmenopausal women with estrogen and progesterone receptor-positive/HER2-negative (ER+/PgR+/HER2-) early breast cancer (EBC)
2011 ◽
Vol 32
(5)
◽
pp. 704-709
◽
Keyword(s):
1995 ◽
Vol 191
(1)
◽
pp. 16-24
◽
1993 ◽
Vol 99
(1)
◽
pp. 8-12
◽